Management of Papillary Thyroid Microcarcinoma

Juan P. Brito; Ian D. Hay

doi:10.1016/j.ecl.2018.10.006

Management of Papillary Thyroid Microcarcinoma

Juan P. Brito, Ian D. Hay

Endocrinology, Diabetes, Metabolism, and Nutrition

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The worldwide incidence of thyroid cancer is increasing. A third of new thyroid cancer cases are papillary thyroid microcarcinoma (PTM), which are 1 cm or less. These tumors are mostly indolent with excellent prognosis. Although thyroid surgery is the most common management option for patients with PTM, new management options demand that treatment decisions must be individualized and based on patient's preference, context, and biology. This article describes management options for PTM patients and shared decision-making as a novel method for individualizing care.

Original language	English (US)
Pages (from-to)	199-213
Number of pages	15
Journal	Endocrinology and Metabolism Clinics of North America
Volume	48
Issue number	1
DOIs	https://doi.org/10.1016/j.ecl.2018.10.006
State	Published - Mar 2019

Keywords

Management
Microcarcinoma
Papillary thyroid cancer
Shared decision-making

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1016/j.ecl.2018.10.006

Cite this

@article{3579ff3e35cd446a9091114217d22e9b,

title = "Management of Papillary Thyroid Microcarcinoma",

abstract = "The worldwide incidence of thyroid cancer is increasing. A third of new thyroid cancer cases are papillary thyroid microcarcinoma (PTM), which are 1 cm or less. These tumors are mostly indolent with excellent prognosis. Although thyroid surgery is the most common management option for patients with PTM, new management options demand that treatment decisions must be individualized and based on patient's preference, context, and biology. This article describes management options for PTM patients and shared decision-making as a novel method for individualizing care.",

keywords = "Management, Microcarcinoma, Papillary thyroid cancer, Shared decision-making",

author = "Brito, {Juan P.} and Hay, {Ian D.}",

note = "Funding Information: Disclosure: J.P. Brito is supported by the Karl-Erivan Haub Family Career Development Award in Cancer Research at Mayo Clinic in Rochester, honoring Richard F. Emslander, MD. I.D. Hay is funded by the Richard F. Emslander Professorship in Endocrine Research, the William Stamps Farrish Fund, and the Colin and Brenda Reed Family Foundation. Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2019",

month = mar,

doi = "10.1016/j.ecl.2018.10.006",

language = "English (US)",

volume = "48",

pages = "199--213",

journal = "Endocrinology and Metabolism Clinics of North America",

issn = "0889-8529",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Management of Papillary Thyroid Microcarcinoma

AU - Brito, Juan P.

AU - Hay, Ian D.

N1 - Funding Information: Disclosure: J.P. Brito is supported by the Karl-Erivan Haub Family Career Development Award in Cancer Research at Mayo Clinic in Rochester, honoring Richard F. Emslander, MD. I.D. Hay is funded by the Richard F. Emslander Professorship in Endocrine Research, the William Stamps Farrish Fund, and the Colin and Brenda Reed Family Foundation. Publisher Copyright: © 2018 Elsevier Inc.

PY - 2019/3

Y1 - 2019/3

N2 - The worldwide incidence of thyroid cancer is increasing. A third of new thyroid cancer cases are papillary thyroid microcarcinoma (PTM), which are 1 cm or less. These tumors are mostly indolent with excellent prognosis. Although thyroid surgery is the most common management option for patients with PTM, new management options demand that treatment decisions must be individualized and based on patient's preference, context, and biology. This article describes management options for PTM patients and shared decision-making as a novel method for individualizing care.

AB - The worldwide incidence of thyroid cancer is increasing. A third of new thyroid cancer cases are papillary thyroid microcarcinoma (PTM), which are 1 cm or less. These tumors are mostly indolent with excellent prognosis. Although thyroid surgery is the most common management option for patients with PTM, new management options demand that treatment decisions must be individualized and based on patient's preference, context, and biology. This article describes management options for PTM patients and shared decision-making as a novel method for individualizing care.

KW - Management

KW - Microcarcinoma

KW - Papillary thyroid cancer

KW - Shared decision-making

UR - http://www.scopus.com/inward/record.url?scp=85058802912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058802912&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2018.10.006

DO - 10.1016/j.ecl.2018.10.006

M3 - Review article

C2 - 30717902

AN - SCOPUS:85058802912

VL - 48

SP - 199

EP - 213

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 1

ER -

Management of Papillary Thyroid Microcarcinoma

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this